Welcome
HARIBOSS is a curated database of RNA-small molecules structures retrieved from the PDB. HARIBOSS is regularly updated with all the structures resolved by X-ray, NMR, and cryo-EM, in which ligands with drug-like properties interact with RNA molecules. Each HARIBOSS entry is annotated with physico-chemical properties of ligands and RNA pockets. HARIBOSS provides researchers with a tool to aid the development of rational design strategies to target RNA with small molecules.
Original paper : HARIBOSS: a curated database of RNA-small molecules structures to aid rational drug design
Latest paper : HARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design
Explore database
Team
Matteo Marengo
Matteo Marengo is a PhD student at Institut Pasteur (Paris, France) and Sanofi (Vitry sur Seine, France) since March 2025. He has a background in biomedical engineering, nanobiotechnology and applied mathematics. He is interested in applying AI algorithms to solve medical and biological challenges.
View profile
Evi Gkeka
Evi Gkeka is an applied mathematician and computational chemist with more than 15 years of research experience in molecular modeling. She has been member of the computer-aided drug design group at Sanofi R&D since 2016. Her work is focused on the development and application of computational methods that can revolutionize drug discovery.
View profile
Max Bonomi
Max Bonomi is a CNRS research director and head of the “Computational Structural Biology” unit at Institut Pasteur (Paris, France). His lab is focused on the development and application of integrative computational/experimental approaches to study structural and dynamic properties of biological systems. More info can be found on the Computational Structural Biology lab page.
View profileFormer Member
Francesco Paolo Panei
Francesco Paolo Panei was a PhD student at Institut Pasteur (Paris, France) and Sanofi (Chilly-Mazarin, France) from 2021 to 2024. Francesco has a background in theoretical physics and he was interested in applying its methods to tackle relevant biological problems, especially related to therapeutic applications.
See publications